Clinical Trial Update: Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

View source ↗

Summary

Clinical trial update examining biomarkers that predict response to tamoxifen and letrozole in postmenopausal women with primary breast cancer treated on CAN-NC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Breast Cancer | Status: UNKNOWN